SUSMED,Inc. (TYO:4263)
888.00
-27.00 (-2.95%)
At close: Nov 10, 2025
SUSMED,Inc. Revenue
SUSMED,Inc. had revenue of 45.00M JPY in the quarter ending September 30, 2025, with 40.63% growth. This brings the company's revenue in the last twelve months to 475.00M, up 38.89% year-over-year. In the fiscal year ending June 30, 2025, SUSMED,Inc. had annual revenue of 462.00M with 35.09% growth.
Revenue (ttm)
475.00M
Revenue Growth
+38.89%
P/S Ratio
31.43
Revenue / Employee
11.05M
Employees
43
Market Cap
14.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 462.00M | 120.00M | 35.09% |
| Jun 30, 2024 | 342.00M | -188.00M | -35.47% |
| Jun 30, 2023 | 530.00M | 214.00M | 67.72% |
| Jun 30, 2022 | 316.00M | 201.00M | 174.78% |
| Jun 30, 2021 | 115.00M | 81.00M | 238.24% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.04T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |